MedPath

A clinical study of Gokshuradi Guggulu prepared with two types in patients of urinary tract infection( mutrakriccha)

Phase 2
Conditions
Health Condition 1: N390- Urinary tract infection, site notspecified
Registration Number
CTRI/2023/10/058892
Lead Sponsor
Government Ayurvedic College
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. patients presenting with the sign and symptoms of Mutrakriccha w.s.r. UTI

2. patients who are giving consent to study.

Exclusion Criteria

1. patients with STD( sexually transmitted diseases.

2. if congenital anomaly of kidney, ureter, urinary bladder, or urethra.

3. patients with systemic disorders like hypertension , tuberculosis etc.

4. lactating mother or pregnant women.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Subjective parameter- grading will be done with the signs and symptoms of mutrakriccha i.e uti <br/ ><br>urine routine & microscopic, Hb , TLC ,DLC, ESR, SGOT/SGPT,S. CREATININ, UREATimepoint: After 21 days intervenetion of gokshuradi guggulu orally and 10 days after stopping the medicine
Secondary Outcome Measures
NameTimeMethod
Grading will be done with signs & symptoms of mutrakriccha <br/ ><br>urine routine & microscopic <br/ ><br>Hb <br/ ><br>TLC <br/ ><br>DLC <br/ ><br>ESR <br/ ><br>SGOT SGPT <br/ ><br>SERUM CREATININ <br/ ><br>UREATimepoint: After 21 days intervenetion of gokshuradi guggulu orally & 10 days after stopping the medicine
© Copyright 2025. All Rights Reserved by MedPath